2013 -- H 5063

=======

LC00046

=======

STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2013

____________

A N A C T

RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCE ACT

     

     

     Introduced By: Representatives Corvese, McNamara, O'Brien, Azzinaro, and Malik

     Date Introduced: January 10, 2013

     Referred To: House Judiciary

It is enacted by the General Assembly as follows:

1-1

     SECTION 1. Section 21-28-2.0.8 of the General Laws in Chapter 21-28 entitled

1-2

"Uniform Controlled Substances Act" is hereby amended to read as follows:

1-3

     21-28-2.08. Contents of schedules. -- Schedule I

1-4

      (a) Schedule I shall consist of the drugs and other substances, by whatever official name,

1-5

common or usual name, chemical name, or brand name designated, listed in this section.

1-6

      (b) Opiates. - Unless specifically excepted or unless listed in another schedule, any of

1-7

the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and

1-8

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

1-9

specific chemical designation:

1-10

      (1) Acetylmethadol

1-11

      (2) Allylprodine

1-12

      (3) Alphacetylmethadol

1-13

      (4) Alphameprodine

1-14

      (5) Alphamethadol

1-15

      (6) Benzethidine

1-16

      (7) Betacetylmethadol

1-17

      (8) Betameprodine

1-18

      (9) Betamethadol

1-19

      (10) Betaprodine

2-20

      (11) Clonitazene

2-21

      (12) Dextromoramide

2-22

      (13) Difenoxin

2-23

      (14) Diampromide

2-24

      (15) Diethylthiambutene

2-25

      (16) Dimenoxadol

2-26

      (17) Dimepheptanol

2-27

      (18) Dimethylthiambutene

2-28

      (19) Dioxaphetyl butyrate

2-29

      (20) Dipipanone

2-30

      (21) Ethylmethylthiambutene

2-31

      (22) Etonitazene

2-32

      (23) Extoxerdine

2-33

      (24) Furethidine

2-34

      (25) Hydroxypethidine

2-35

      (26) Ketobemidone

2-36

      (27) Levomoramide

2-37

      (28) Levophenacylmorphan

2-38

      (29) Morpheridine

2-39

      (30) Noracymethadol

2-40

      (31) Norlevorphanol

2-41

      (32) Normethadone

2-42

      (33) Norpipanone

2-43

      (34) Phenadoxone

2-44

      (35) Phenampromide

2-45

      (36) Phenomorphan

2-46

      (37) Phenoperidine

2-47

      (38) Piritramide

2-48

      (39) Proheptazine

2-49

      (40) Properidine

2-50

      (41) Propiram

2-51

      (42) Racemoramide

2-52

      (43) Trimeperidone

2-53

      (44) Tilidine

3-54

      (45) Alpha-methylfentanyl

3-55

      (46) Beta-hydroxy-3-methylfentanyl other names:

3-56

      N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl] Nphenylpropanamide

3-57

      (c) Opium Derivatives. - Unless specifically excepted or unless listed in another

3-58

schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever

3-59

the existence of the salts, isomers, and salts of isomers is possible within the specific chemical

3-60

designation:

3-61

      (1) Acetorphine

3-62

      (2) Acetyldihydrocodeine

3-63

      (3) Benzylmorphine

3-64

      (4) Codeine methylbromide

3-65

      (5) Codeine-N-Oxide

3-66

      (6) Cyprenorphine

3-67

      (7) Desomorphine

3-68

      (8) Dihydromorphine

3-69

      (9) Etorphine (Except hydrochloride salt)

3-70

      (10) Heroin

3-71

      (11) Hydromorphinol

3-72

      (12) Methyldesorphine

3-73

      (13) Methylihydromorphine

3-74

      (14) Morphine methylbromide

3-75

      (15) Morphine methylsulfonate

3-76

      (16) Morphine-N-Oxide

3-77

      (17) Myrophine

3-78

      (18) Nococodeine

3-79

      (19) Nicomorphine

3-80

      (20) Normorphine

3-81

      (21) Pholcodine

3-82

      (22) Thebacon

3-83

      (23) Drotebanol

3-84

      (d) Hallucinogenic Substances. - Unless specifically excepted or unless listed in another

3-85

schedule, any material, compound, mixture, or preparation, which contains any quantity of the

3-86

following hallucinogenic substances, or which contains any of its salts, isomers, and salts of

3-87

isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the

3-88

specific chemical designation (for purposes of this subsection only, the term "isomer" includes

4-1

the optical, position, and geometric isomers):

4-2

      (1) 3, 4-methylenedioxy amphetamine

4-3

      (2) 5-methoxy-3, 4-methylenedioxy amphetamine

4-4

      (3) 3, 4, 5-trimethoxy amphetamine

4-5

      (4) Bufotenine

4-6

      (5) Diethyltryptamine

4-7

      (6) Dimethyltryptamine

4-8

      (7) 4-methyl 2, 5-dimethoxyamphetamine

4-9

      (8) Ibogaine

4-10

      (9) Lysergic acid diethylamide

4-11

      (10) Marihuana

4-12

      (11) Mescaline

4-13

      (12) Peyote. Meaning all parts of the plant presently classified botanically as

4-14

Lophophora Williamsii Lemair whether growing or not; the seeds of the plant; any extract from

4-15

any part of the plant; and any compound, manufacture, salt, derivative, mixture, or preparation of

4-16

the plant, its seeds or extracts.

4-17

      (13) N-ethyl-3-piperidyl benzilate

4-18

      (14) N-methyl-3-piperidyl benzilate

4-19

      (15) Psilocybin

4-20

      (16) Psilocyn

4-21

      (17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the

4-22

plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and

4-23

their isomers with similar chemical structure and pharmacological activity such as the following:

4-24

delta 1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans

4-25

tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and

4-26

its optical isomer. (Since nomenclature of these substances is not internationally standardized,

4-27

compounds of these structures, regardless of numerical designation of atomic positions covered).

4-28

      (18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2-

4-29

Thienyl analog of phencyclidine: TPCP

4-30

      (19) 2,5 dimethoxyamphetamine

4-31

      (20) 4-bromo-2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxy-alpha-

4-32

methylphenethyamine: 4-bromo-2,5-DMA

4-33

      (21) 4-methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine:

4-34

paramethoxyamphetamine: PMA

5-1

      (22) Ethylamine analog of phencyclidine. N-ethyl-1- phenylcyclohexylamine, (1-

5-2

phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE

5-3

      (23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)- pyrrolidine PCPy, PHP

5-4

      (24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-

5-5

6,6,9-trimethyl-6H-dibenz o (b,d) pyran: Synhexyl.

5-6

      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any

5-7

material, compound, mixture, or preparation which contains any quantity of the following

5-8

substances having a depressant effect on the central nervous system, including its salts, isomers,

5-9

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

5-10

within the specific chemical designation:

5-11

      (1) Mecloqualone.

5-12

      (2) Methaqualone.

5-13

      (3) 3-methyl fentanyl (n-( ethyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide.

5-14

      (4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional and

5-15

geometric isomers, salts, and salts of isomers.

5-16

      (5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts and

5-17

salts of isomers.

5-18

      (6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts

5-19

and salts of isomers.

5-20

      (7) N-(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-alpha-

5-21

methylfentanyl), its optical isomers, salts and salts of isomers.

5-22

      (8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha-

5-23

methylthiofentanyl), its optical isomers, salts and salts of isomers.

5-24

      (9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers,

5-25

salts and salts of isomers.

5-26

      (10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta-

5-27

hydroxyfentanyl), its optical isomers, salts and salts of isomers.

5-28

      (11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta-

5-29

hydroxy-3-methylfentanyl), its optical and geometric isomers, salts and salts of isomers.

5-30

      (12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro- panamide (3-

5-31

methylthiofentanyl), its optical and geometric isomers, salts and salts of isomers.

5-32

      (13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its

5-33

optical isomers, salts and salts of isomers.

6-34

      (14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical

6-35

isomers, salts and salts of isomers.

6-36

      (15) N-[1-(2-phenylethyl)-4-piperidyl]N-(4-fluorophenyl)-propanamid e (para-

6-37

fluorofentanyl), its optical isomers, salts and salts of isomers.

6-38

      (16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or

6-39

geometric isomers, salts and salts of isomers.

6-40

     (17) Salvia Divinorum (Salvinorin A or Divinorin A).

6-41

     (18) Datura stamonium (gypsum weed or jimsom weed).

6-42

     (19) Synthetic cannabinoids (synthetic marijuana).

6-43

      (f) Stimulants. - Unless specifically excepted or unless listed in another schedule, any

6-44

material, compound, mixture, or preparation which contains any quantity of the following

6-45

substances having a stimulant effect on the central nervous system, including its salts, isomers,

6-46

and salts of isomers:

6-47

      (1) Fenethylline

6-48

      (2) N-ethylamphetamine

6-49

      (3) 4-methyl-N-methylcathinone (Other name: mephedrone)

6-50

      (4) 3,4-methylenedioxy-N-methlycathinone (Other name: methylone)

6-51

      (5) 3,4-methylenedioxypyrovalerone (Other name: MDPV)

6-52

      (g) Any material, compound, mixture or preparation which contains any quantity of the

6-53

following substances:

6-54

      (1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol (CP-47,497)

6-55

      (2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol

6-56

(cannabicyclohexanol and CP-47,497 c8 homologue)

6-57

      (3) 1-Butyl-3-(1 naphthoyl)indole, (JWH-073)

6-58

      (4) 1-[2-(4-Morpholinyl)ethyl]3-(1-naphthoyl)indole (JWH-200)

6-59

      (5) 1-Pentyl-3-(1-napthoyl)indole, (JWH-018 and AM678)

6-60

      Schedule II

6-61

      (a) Schedule II shall consist of the drugs and other substances, by whatever official

6-62

name, common or usual name, chemical name, or brand name designated, listed in this section.

6-63

      (b) Substances, vegetable origin or chemical synthesis. - Unless specifically excepted or

6-64

unless listed in another schedule, any of the following substances whether produced directly or

6-65

indirectly by extraction from substances of vegetable origin, or independently by means of

6-66

chemical synthesis, or by a combination of extraction and chemical synthesis:

6-67

      (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or

6-68

opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the

7-1

following:

7-2

      (i) Raw opium

7-3

      (ii) Opium extracts

7-4

      (iii) Opium fluid extracts

7-5

      (iv) Powdered opium

7-6

      (v) Granulated opium

7-7

      (vi) Tincture of opium

7-8

      (vii) Etorphine hydrochloride

7-9

      (viii) Codeine

7-10

      (ix) Ethylmorphine

7-11

      (x) Hydrocodone

7-12

      (xi) Hydromorphone

7-13

      (xii) Metopon

7-14

      (xiii) Morphine

7-15

      (xiv) Oxycodone

7-16

      (xv) Oxymorphone

7-17

      (xvi) Thebaine

7-18

      (2) Any salt, compound, derivative, or preparation which is chemically equivalent or

7-19

identical with any of the substances referred to in subdivision (1) of this subsection, except that

7-20

these substances shall not include the isoquinoline alkaloids of opium.

7-21

      (3) Opium poppy and poppy straw.

7-22

      (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and

7-23

any salt, compound, derivative, or preparation which is chemically equivalent or identical with

7-24

any of these substances, except that the substances shall not include decocainized coca leaves or

7-25

extraction of coca leaves, which extractions do not contain cocaine or ecgonine.

7-26

      (5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or

7-27

powder form which contains the phenanthrine alkaloids of the opium poppy).

7-28

      (c) Opiates. - Unless specifically excepted or unless listed in another schedule any of the

7-29

following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters and,

7-30

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

7-31

specific chemical designation:

7-32

      (1) Alphaprodine

7-33

      (2) Anileridine

8-34

      (3) Bezitramide

8-35

      (4) Dihydrocodeine

8-36

      (5) Diphenoxylate

8-37

      (6) Fentanyl

8-38

      (7) Isomethadone

8-39

      (8) Levomethorphan

8-40

      (9) Levorphanol

8-41

      (10) Metazocine

8-42

      (11) Methadone

8-43

      (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane

8-44

      (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic

8-45

acid

8-46

      (14) Pethidine

8-47

      (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

8-48

      (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

8-49

      (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

8-50

      (18) Phenaxocine

8-51

      (19) Piminodine

8-52

      (20) Racemethorphan

8-53

      (21) Racemorphan

8-54

      (22) Bulk Dextropropoxyphene (non-dosage forms)

8-55

      (23) Suffentanil

8-56

      (24) Alfentanil

8-57

      (25) Levoalphacetylmethadol

8-58

      (d) Stimulants. - Unless specifically excepted or unless listed in another schedule, any

8-59

material, compound, mixture, or preparation which contains any quantity of the following

8-60

substances having a stimulant effect on the central nervous system:

8-61

      (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers.

8-62

      (2) Methamphetamine, its salts and salts of its isomers.

8-63

      (3) Phenmetrazine and its salts.

8-64

      (4) Methylphenidate.

8-65

      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any

8-66

material, compound, mixture, or preparation which contains any quantity of the following

8-67

substances having a depressant effect on the central nervous system, including its salts, isomers,

8-68

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

9-1

within the specific chemical designation:

9-2

      (1) Amobarbital

9-3

      (2) Glutethimide

9-4

      (3) Methyprylon

9-5

      (4) Pentobarbital

9-6

      (5) Phencyclidine

9-7

      (6) Secobarbital

9-8

      (7) Phencyclidine immediate precursors:

9-9

      (i) 1-phencyclohexylamine

9-10

      (ii) 1-piperidinocyclohexane-carbonitrile (PCC)

9-11

      (8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some

9-12

other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone.

9-13

      Schedule III

9-14

      (a) Unless specifically excepted or unless listed in another schedule, any material,

9-15

compound, mixture, or preparation which contains any quantity of the following substances

9-16

having a depressant effect on the central nervous system:

9-17

      (1) Any substance which contains any quantity of a derivative of barbituric acid, or any

9-18

salt of a derivative of barbituric acid.

9-19

      (2) Chlorhexadol

9-20

      (3) Lysergic acid

9-21

      (4) Lysergic acid amide

9-22

      (5) Sulfondiethylmethane

9-23

      (6) Sulfonethylmethane

9-24

      (7) Sylfonmethane

9-25

      (8) Any compound, mixture, or preparation containing amobarbital, secobarbital,

9-26

pentobarbital, or any salt of them and one or more other active medicinal ingredients which are

9-27

not listed in any schedule.

9-28

      (9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or

9-29

any salt of any of these drugs and approved by the Food and Drug Administration for marketing

9-30

only as a suppository.

9-31

      (10) Ketamine, its salts, isomers and salts of isomers. (Some other names for ketamine:

9-32

(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone).

9-33

      (b) Unless specifically excepted or unless listed in another schedule, any material,

9-34

compound, mixture, or preparation containing limited quantities of any of the following narcotic

10-1

drugs, or any salts of them:

10-2

      (1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

10-3

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal

10-4

or greater quantity of an isoquinoline alkaloid of opium.

10-5

      (2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

10-6

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or

10-7

more active, nonnarcotic ingredients in recognized therapeutic amounts.

10-8

      (3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

10-9

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-10

a fourfold or greater quantity of an isoquinoline alkaloid of opium.

10-11

      (4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

10-12

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-13

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-14

      (5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one

10-15

hundred milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with

10-16

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-17

      (6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one

10-18

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

10-19

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

10-20

      (7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred

10-21

milliliters (100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five

10-22

milligrams (25 mgs.) per dosage unit, with one or more active nonnarcotic ingredients in

10-23

recognized therapeutic amounts.

10-24

      (8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters

10-25

(100 mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in

10-26

recognized therapeutic amounts.

10-27

      (c) Stimulants. - Unless specifically excepted or listed in another schedule, any material,

10-28

compound, mixture, or preparation which contains any quantity of the following substances

10-29

having a stimulant effect on the central nervous system, including its salts, isomers, and salts of

10-30

the isomers whenever the existence of the salts of isomers is possible within the specific chemical

10-31

designation:

10-32

      (1) Benzphetamine

10-33

      (2) Chlorphentermine

11-34

      (3) Clortermine

11-35

      (4) Mazindol

11-36

      (5) Phendimetrazine

11-37

      (d) Steroids and hormones. - Anabolic steroids (AS) or human growth hormone (HGH),

11-38

excluding those compounds, mixtures, or preparations containing an anabolic steroid that because

11-39

of its concentration, preparation, mixture or delivery system, has no significant potential for

11-40

abuse, as published in 21 CFR 1308.34, including, but not limited to, the following:

11-41

      (1) Chlorionic gonadotropin

11-42

      (2) Clostebol

11-43

      (3) Dehydrochlormethyltestosterone

11-44

      (4) Ethylestrenol

11-45

      (5) Fluoxymesterone

11-46

      (6) Mesterolone

11-47

      (7) Metenolone

11-48

      (8) Methandienone

11-49

      (9) Methandrostenolone

11-50

      (10) Methyltestosterone

11-51

      (11) Nandrolone decanoate

11-52

      (12) Nandrolone phenpropionate

11-53

      (13) Norethandrolone

11-54

      (14) Oxandrolone

11-55

      (15) Oxymesterone

11-56

      (16) Oxymetholone

11-57

      (17) Stanozolol

11-58

      (18) Testosterone propionate

11-59

      (19) Testosterone-like related compounds

11-60

      (20) Human Growth Hormone (HGH)

11-61

      (e) Hallucinogenic substances.

11-62

      (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in

11-63

U.S. Food and Drug Administration approved drug product. (Some other names for dronabinol:

11-64

(6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H- dibenzo[b,d]yra n-1-ol,or(-)-

11-65

delta-9(trans)-tetrahydrocannabinol.)

11-66

      Schedule IV

11-67

      (1) Barbital.

12-68

      (2) Chloral betaine

12-69

      (3) Chloral hydrate

12-70

      (4) Ethchrovynol

12-71

      (5) Ethinamate

12-72

      (6) Methohexital

12-73

      (7) Meprobamate

12-74

      (8) Methylphenobarbital

12-75

      (9) Paraldehyde

12-76

      (10) Petrichloral

12-77

      (11) Phenobarbital

12-78

      (12) Fenfluramine

12-79

      (13) Diethylpropion

12-80

      (14) Phentermine

12-81

      (15) Pemoline (including organometallic complexes and chelates thereof).

12-82

      (16) Chlordiazepoxide

12-83

      (17) Clonazepam

12-84

      (18) Clorazepate

12-85

      (19) Diazepam

12-86

      (20) Flurazepam

12-87

      (21) Mebutamate

12-88

      (22) Oxazepam

12-89

      (23) Unless specifically excepted or unless listed in another schedule, any material,

12-90

compound, mixture, or preparation which contains any quantity of the following substances,

12-91

including its salts:

12-92

      Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3- methyl-2-

12-93

propronoxybutane).

12-94

      (24) Prazepam

12-95

      (25) Lorazepam

12-96

      (26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25)

12-97

micrograms of atropine sulfate per dosage unit.

12-98

      (27) Pentazocine

12-99

      (28) Pipradrol

12-100

      (29) SPA (-)-1-dimethylamino-1, 2-diphenylethane

12-101

      (30) Temazepam

13-102

      (31) Halazepam

13-103

      (32) Alprazolam

13-104

      (33) Bromazepam

13-105

      (34) Camazepam

13-106

      (35) Clobazam

13-107

      (36) Clotiazepam

13-108

      (37) Cloxazolam

13-109

      (38) Delorazepam

13-110

      (39) Estazolam

13-111

      (40) Ethyl Ioflazepate

13-112

      (41) Fludizaepam

13-113

      (42) Flunitrazepam

13-114

      (43) Haloxazolam

13-115

      (44) Ketazolam

13-116

      (45) Loprazolam

13-117

      (46) Lormetazepam

13-118

      (47) Medazepam

13-119

      (48) Nimetazepam

13-120

      (49) Nitrazepam

13-121

      (50) Nordiazepam

13-122

      (51) Oxazolam

13-123

      (52) Pinazepam

13-124

      (53) Tetrazepam

13-125

      (54) Mazindol

13-126

      (55) Triazolam

13-127

      (56) Midazolam

13-128

      (57) Quazepam

13-129

      (58) Butorphanol

13-130

      (59) Sibutramine

13-131

      Schedule V

13-132

      (a) Any compound, mixture, or preparation containing any of the following limited

13-133

quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal

13-134

ingredients in sufficient proportion to confer upon the compound, mixture, or preparation

13-135

valuable medicinal qualities other than those possessed by the narcotic drug alone:

14-136

      (1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100

14-137

mls.) or per one hundred grams (100 gms.).

14-138

      (2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100

14-139

milliliters (100 mls.) or per one hundred grams (100 gms.).

14-140

      (3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100

14-141

milliliters (100 mls.) or per one hundred grams (100 gms.).

14-142

      (4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less

14-143

than twenty-five (25) micrograms of atropine sulfate per dosage unit.

14-144

      (5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred

14-145

milliliters (100 mls.) or per one hundred grams (100 gms.).

14-146

      (b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than

14-147

twenty-five (25) micrograms of atropine sulfate per dosage unit.

14-148

      (c) Buprenorphine

14-149

      (d) Unless specifically exempted or excluded or unless listed in another schedule, any

14-150

material, compound, mixture, or preparation which contains any quantity of the following

14-151

substances having a stimulant effect on the central nervous system, including its salts, isomers

14-152

and salts of isomers:

14-153

      (1) Propylhexedrine (except as benzedrex inhaler)

14-154

      (2) Pyrovalerone.

14-155

     SECTION 2. This act shall take effect upon passage.

     

=======

LC00046

=======

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N A C T

RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCE ACT

***

15-1

     This act would add the hallucinogenic drugs Salvia Divinorum (Salvinorin A or

15-2

Divinorin A), Datura stramonmium (gypsum weed or jimsom weed) and synthetic cannabinoids

15-3

(synthetic marijuana) to the Rhode Island Controlled Substances Act Schedule 1, the misuse of

15-4

which may result in the requisite criminal penalties for abuse.

15-5

     This act would take effect upon passage.

     

=======

LC00046

=======

H5063